Categories: HardwareITPlatform
Mitrassist is a leading angiocarpy treatment devices platform with globally cutting-edge innovation. It has introduced a minimally invasive approach to Mitral Regurgitation (MR) treatment that is neither repair nor replacement. The company’s “valve-in-valve” approach overcomes the various challenges of MR and offers an improved treatment solution for all MR patients.
Investors 2
Funding Rounds 1
| Date | Series | Amount | Investors |
| 28.09.2023 | Series C | $100M | - |
Mentions in press and media 2
Reviews 0
